KEGG   VARIANT: 4893v1
Entry
4893v1                      Variant                                
Name
NRAS mutation
Type
Gain of function
Gene
NRAS  NRAS proto-oncogene, GTPase [KO:K07828]
Organism
hsa_var Human gene variants (Homo sapiens)
Variation
mutation G13V
ClinVar: 375876
dbSNP: rs121434596
COSM: 574
Variation
mutation G13D
ClinVar: 13901
dbSNP: rs121434596
COSM: 573
Variation
mutation Q61R
ClinVar: 13900 375873 376220
dbSNP: rs11554290 rs1057519695 rs1057519834
COSM: 584
Variation
mutation Q61H
ClinVar: 375871 373003
dbSNP: rs12193255 rs12193255
Variation
mutation G12D
ClinVar: 39648
dbSNP: rs12193237
COSM:564
Variation
mutation Q61K
ClinVar: 73058
dbSNP: rs121913254
COSM:580
Variation
mutation Q61L
ClinVar: 375872 375874
dbSNP: rs1057519695 rs11554290
Variation
mutation G12S
ClinVar: 177778
dbSNP: rs121913250
COSM: 563
Variation
mutation G13S
ClinVar: 376221
dbSNP: rs121434595
COSM: 571
Network
nt06210  ERK signaling (cancer)
nt06214  PI3K signaling (cancer)
nt06260  Colorectal cancer
nt06261  Gastric cancer
nt06262  Pancreatic cancer
nt06266  Non-small cell lung cancer
nt06268  Melanoma
nt06271  Endometrial cancer
nt06274  Thyroid cancer
nt06275  Acute myeloid leukemia
nt06526  MAPK signaling
nt06530  PI3K signaling
Disease
H00003  Acute myeloid leukemia
H00014  Non-small cell lung cancer
H00018  Gastric cancer
H00019  Pancreatic cancer
H00020  Colorectal cancer
H00026  Endometrial cancer
H00032  Thyroid cancer
H00038  Melanoma
Reference
PMID:3103719
  Authors
Bos JL, Verlaan-de Vries M, van der Eb AJ, Janssen JW, Delwel R, Lowenberg B, Colly LP
  Title
Mutations in N-ras predominate in acute myeloid leukemia.
  Journal
Blood 69:1237-41 (1987)
Reference
PMID:2674680
  Authors
van 't Veer LJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, Schrier PI, Bos JL
  Title
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
  Journal
Mol Cell Biol 9:3114-6 (1989)
DOI:10.1128/MCB.9.7.3114
Reference
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
  Authors
Takahashi N, Yamada Y, Taniguchi H, Fukahori M, Sasaki Y, Shoji H, Honma Y, Iwasa S, Takashima A, Kato K, Hamaguchi T, Shimada Y
  Title
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.
  Journal
BMC Res Notes 7:271 (2014)
DOI:10.1186/1756-0500-7-271
LinkDB

DBGET integrated database retrieval system